Stanisław Ochudlo

1.1k total citations
34 papers, 542 citations indexed

About

Stanisław Ochudlo is a scholar working on Neurology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Stanisław Ochudlo has authored 34 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 6 papers in Physiology and 6 papers in Psychiatry and Mental health. Recurrent topics in Stanisław Ochudlo's work include Botulinum Toxin and Related Neurological Disorders (11 papers), Neurological disorders and treatments (9 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Stanisław Ochudlo is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (11 papers), Neurological disorders and treatments (9 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Stanisław Ochudlo collaborates with scholars based in Poland, United States and Germany. Stanisław Ochudlo's co-authors include Grzegorz Opala, Joanna Siuda, Andrzej Friedman, Jarosław Sławek, Marta Banach, Stewart A. Factor, Hubert H. Fernandez, Robert A. Hauser, Agnieszka Gorzkowska and William G. Ondo and has published in prestigious journals such as PLoS ONE, Neurology and Journal of the Neurological Sciences.

In The Last Decade

Stanisław Ochudlo

31 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stanisław Ochudlo Poland 10 371 127 120 95 43 34 542
D Mateo Spain 14 397 1.1× 101 0.8× 164 1.4× 92 1.0× 44 1.0× 33 633
Ján Benetin Slovakia 10 315 0.8× 88 0.7× 48 0.4× 37 0.4× 42 1.0× 22 479
Christopher Ngai United States 5 172 0.5× 126 1.0× 42 0.3× 189 2.0× 32 0.7× 11 534
P. De Deyn Belgium 7 218 0.6× 112 0.9× 36 0.3× 117 1.2× 79 1.8× 11 431
Randall P. Brewer United States 12 262 0.7× 60 0.5× 68 0.6× 285 3.0× 86 2.0× 21 722
J.C. Desport France 6 745 2.0× 87 0.7× 42 0.3× 90 0.9× 69 1.6× 17 872
Kosuke Matsuzono Japan 11 81 0.2× 120 0.9× 37 0.3× 73 0.8× 65 1.5× 64 434
Gabriele Ronchetti Italy 7 195 0.5× 54 0.4× 63 0.5× 48 0.5× 16 0.4× 13 309
Zlatko Trkanjec Croatia 9 114 0.3× 35 0.3× 52 0.4× 52 0.5× 38 0.9× 43 346
Jon Westbrook United Kingdom 8 350 0.9× 22 0.2× 85 0.7× 82 0.9× 94 2.2× 17 733

Countries citing papers authored by Stanisław Ochudlo

Since Specialization
Citations

This map shows the geographic impact of Stanisław Ochudlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanisław Ochudlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanisław Ochudlo more than expected).

Fields of papers citing papers by Stanisław Ochudlo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanisław Ochudlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanisław Ochudlo. The network helps show where Stanisław Ochudlo may publish in the future.

Co-authorship network of co-authors of Stanisław Ochudlo

This figure shows the co-authorship network connecting the top 25 collaborators of Stanisław Ochudlo. A scholar is included among the top collaborators of Stanisław Ochudlo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanisław Ochudlo. Stanisław Ochudlo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jost, Wolfgang H., A. Friedman, Olaf Michel, et al.. (2023). Long-term incobotulinumtoxinA treatment for chronic sialorrhea: efficacy and safety over 64 weeks. Parkinsonism & Related Disorders. 113.
2.
Jost, Wolfgang H., A. Friedman, Olaf Michel, et al.. (2023). Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea. Parkinsonism & Related Disorders. 113.
3.
Sarzyńska‐Długosz, Iwona, Anna Szczepańska-Szerej, Artur Drużdż, et al.. (2020). Real-world effectiveness of abobotulinumtoxinA (Dysport®) in adults with upper limb spasticity in routine clinical practice: an observational study. Neurologia i Neurochirurgia Polska. 54(1). 90–99. 4 indexed citations
4.
Jost, Wolfgang H., Andrzej Friedman, Olaf Michel, et al.. (2019). Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks. Parkinsonism & Related Disorders. 70. 23–30. 23 indexed citations
5.
Jost, Wolfgang H., Andrzej Friedman, Olaf Michel, et al.. (2019). SIAXI. Neurology. 92(17). e1982–e1991. 70 indexed citations
6.
Anderson, Karen E., Mat D. Davis, Stewart A. Factor, et al.. (2018). 158 Long-Term Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia: Results From an Open-Label, Long-Term Study. CNS Spectrums. 23(1). 97–97. 2 indexed citations
7.
Fernandez, Hubert H., Mat D. Davis, Stewart A. Factor, et al.. (2018). 134 Improvements in Clinical Global Impression of Change With Deutetrabenazine Treatment in Tardive Dyskinesia From the ARM-TD and AIM-TD Studies. CNS Spectrums. 23(1). 84–84. 1 indexed citations
8.
Anderson, Karen E., David Stamler, Mat D. Davis, et al.. (2017). Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet Psychiatry. 4(8). 595–604. 134 indexed citations
9.
10.
Golańska, Ewa, Małgorzata Szybka, Monika Rudzińska, et al.. (2015). Screening for THAP1 Mutations in Polish Patients with Dystonia Shows Known and Novel Substitutions. PLoS ONE. 10(6). e0129656–e0129656. 2 indexed citations
11.
Ochudlo, Stanisław. (2011). 1.297 SPASTIC DYSTONIA OF HIP ADDUCTOR IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS TREATED WITH BOTULINUM TOXIN TYPE A. Parkinsonism & Related Disorders. 18. S71–S71. 1 indexed citations
12.
Arkuszewski, Michał, et al.. (2010). Cerebral sinus thrombosis as a complication of Crohn's disease: a case report. Advances in Medical Sciences. 55(2). 337–339. 5 indexed citations
13.
Siuda, Joanna, et al.. (2009). Cerebral white matter lesions in patients with dementia – from MCI to severe Alzheimer's disease. Journal of the Neurological Sciences. 283(1-2). 79–82. 45 indexed citations
14.
Piaskowski, Sylwester, Jarosław Sławek, Stanisław Ochudlo, et al.. (2008). Phenotype of the DYT1 mutation in the TOR1A gene in a Polish population of patients with dystonia. A preliminary report.. PubMed. 41(6). 487–94. 7 indexed citations
15.
Sławek, Jarosław, Andrzej Friedman, Anna Potulska‐Chromik, et al.. (2007). Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.. CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche). 22(2). 95–100. 81 indexed citations
16.
Ochudlo, Stanisław, et al.. (2007). Various patterns of gestes antagonistes in cervical dystonia. Parkinsonism & Related Disorders. 13(7). 417–420. 28 indexed citations
17.
Jasińska‐Myga, Barbara, et al.. (2007). Apolipoprotein E Gene Polymorphism, Total Plasma Cholesterol Level, and Parkinson Disease Dementia. Archives of Neurology. 64(2). 261–261. 44 indexed citations
18.
Boczarska‐Jedynak, Magdalena, et al.. (2007). [85-years-old patient with paraneoplastic polyneuropathy].. PubMed. 60(3-4). 189–91. 1 indexed citations
19.
Ochudlo, Stanisław, Piotr Bryniarski, & Grzegorz Opala. (2007). Botulinum toxin improves the quality of life and reduces the intensification of depressive symptoms in patients with blepharospasm. Parkinsonism & Related Disorders. 13(8). 505–508. 30 indexed citations
20.
Opala, Grzegorz & Stanisław Ochudlo. (2004). Obraz kliniczny i różnicowanie otępienia naczyniowego. Via Medica Journals. 6(1). 7–16. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D Mateo Breakdown of academic impact, for papers by Ján Benetin Breakdown of academic impact, for papers by Christopher Ngai Breakdown of academic impact, for papers by P. De Deyn Breakdown of academic impact, for papers by Randall P. Brewer Breakdown of academic impact, for papers by J.C. Desport Breakdown of academic impact, for papers by Kosuke Matsuzono Breakdown of academic impact, for papers by Gabriele Ronchetti Breakdown of academic impact, for papers by Zlatko Trkanjec Breakdown of academic impact, for papers by Jon Westbrook
Rankless by CCL
2026